Merck & Co. (MRK): Let’s roll the dice and play a lil’ Monopoly
April 5th, 2007 • Related • Filed Under
On March 22, 2007 I posted on the possibility of a surge in Merck stock. Technically we are not quite there yet, but shares are starting to move. It has climbed over a dollar since I mentioned it about two weeks ago.
Does this make the stock expensive? Not at all.
Shares are still very attractive and have been in a short-term consolidating phase. It is recommended that you initiate a position and protect your capital via 5% stop loss. This stock should rise about $10 in the six months to follow. A 22% return isn’t too shabby given the time frame.

Good Investing…
More on this topic
(What's this?)
Good message, wrong occasion to send it
(Pharma's Cutting Edge, 4/18/07)
Merck & Co., Inc. (MRK)
(Short-Term Trading, 4/14/07)
(MRK) Merck Updates Migraine Drug Status
(Stock Blog Hub, 9/11/09)
Subscribe



